• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土壤和肠道中共享微生物组的放线菌,作为对抗结肠癌的“老朋友”。

Streptomyces, shared microbiome member of soil and gut, as 'old friends' against colon cancer.

机构信息

School of Life Sciences, University of Nevada Las Vegas, 4505 S. Maryland Parkway, Las Vegas, Nevada 89154, USA.

Institute for Cancer Research, Shiraz University of Medical Sciences, Zand street, Shiraz 71348, Iran.

出版信息

FEMS Microbiol Ecol. 2018 Aug 1;94(8). doi: 10.1093/femsec/fiy120.

DOI:10.1093/femsec/fiy120
PMID:29912397
Abstract

Inflammation contributes to colon cancer initiation. The disease along with allergy and autoimmunity has been on the rise in Western and more recently in developing countries. This shared rise may imply a shared cause. Streptomycetes are known as soil residents and produce numerous antiproliferative, anti-inflammatory/immunosuppressive compounds, e.g. rapamycin and tacrolimus. Recently, Streptomyces has been shown in gut microbiome with a lower prevalence in humans than nonhumans whose microbiomes might be more representative of past humans' in a hunter-gatherer and farming environment. It was previously suggested that Streptomyces producing antiproliferatives/immunosuppressants would be 'old friends' against allergy and autoimmunity as well as inflammatory bowel diseases. Here, it is suggested that these streptomycetes within gut microbiome have also been evolved as 'old friends' to suppress colon tumorigenesis through their numerous antiproliferatives/immunosuppressants. Subsequently, the shortage of exposure to nature in our current lifestyle has cost us the shortage of these friends and vulnerability to colon cancer. An attractive research area in the future would be whether the shortage of Streptomyces exposure can be the underlying reason for colon cancer, allergy and autoimmunity rise, and if the restoration of these 'old friends' through probiotics or more exposure to nature can prevent colon cancer.

摘要

炎症促进结肠癌的发生。这种疾病与过敏和自身免疫性疾病一起,在西方国家以及最近在发展中国家呈上升趋势。这种共同的上升趋势可能意味着存在共同的原因。链霉菌被称为土壤居民,它们产生许多抗增殖、抗炎/免疫抑制化合物,例如雷帕霉素和他克莫司。最近,在肠道微生物组中发现了链霉菌,其在人类中的流行程度低于非人类,而非人类的微生物组可能更能代表过去人类在狩猎采集和农业环境中的情况。此前有人提出,产生抗增殖/免疫抑制剂的链霉菌将成为过敏和自身免疫以及炎症性肠病的“老朋友”。在这里,我们认为肠道微生物组中的这些链霉菌也已经进化为“老朋友”,通过其众多的抗增殖/免疫抑制剂来抑制结肠癌的发生。因此,我们目前的生活方式中缺乏接触大自然的机会,使我们失去了这些朋友,从而更容易患上结肠癌。未来一个有吸引力的研究领域是,接触链霉菌的机会减少是否是结肠癌、过敏和自身免疫性疾病上升的根本原因,以及通过益生菌或更多地接触大自然来恢复这些“老朋友”是否可以预防结肠癌。

相似文献

1
Streptomyces, shared microbiome member of soil and gut, as 'old friends' against colon cancer.土壤和肠道中共享微生物组的放线菌,作为对抗结肠癌的“老朋友”。
FEMS Microbiol Ecol. 2018 Aug 1;94(8). doi: 10.1093/femsec/fiy120.
2
Immunosuppressants produced by Streptomyces: evolution, hygiene hypothesis, tumour rapalog resistance and probiotics.由链霉菌产生的免疫抑制剂:进化、卫生假说、肿瘤雷帕霉素耐药性和益生菌。
Environ Microbiol Rep. 2018 Apr;10(2):123-126. doi: 10.1111/1758-2229.12617. Epub 2018 Feb 7.
3
Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk.利用膳食生物活性物质塑造功能性肠道微生物群,降低结肠癌风险。
Semin Cancer Biol. 2017 Oct;46:191-204. doi: 10.1016/j.semcancer.2017.06.009. Epub 2017 Jul 1.
4
Streptomyces genus as a source of probiotics and its potential for its use in health.链霉菌属作为益生菌的来源及其在健康中的应用潜力。
Microbiol Res. 2023 Jan;266:127248. doi: 10.1016/j.micres.2022.127248. Epub 2022 Oct 31.
5
Microbiome in Colonic Carcinogenesis.肠道微生物组与结直肠癌的发生
Compr Physiol. 2023 Jun 26;13(3):4685-4708. doi: 10.1002/cphy.c210052.
6
Effects of Lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1, 2-dimethylhydrazine-induced rat model.唾液乳杆菌Ren对1,2 - 二甲基肼诱导的大鼠模型中癌症预防及肠道微生物群的影响
J Microbiol. 2015 Jun;53(6):398-405. doi: 10.1007/s12275-015-5046-z. Epub 2015 May 30.
7
Gut Microbiome and Gastrointestinal Cancer: Les liaisons Dangereuses.肠道微生物群与胃肠道癌症:危险的联系
J Clin Gastroenterol. 2016 Nov/Dec;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S191-S196. doi: 10.1097/MCG.0000000000000714.
8
The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis.肠道微生物群与结直肠癌发生过程中炎症的相互关系。
Clin Lab Med. 2014 Dec;34(4):699-710. doi: 10.1016/j.cll.2014.08.002. Epub 2014 Sep 15.
9
Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer.在结肠癌大鼠模型中,益生菌组合引起的微生物群结构变化通过Toll样受体2(TLR2)信号传导增强肠道屏障并降低癌症发生率。
Dig Dis Sci. 2016 Oct;61(10):2908-2920. doi: 10.1007/s10620-016-4238-7. Epub 2016 Jul 6.
10
Interplay of Gut Microbiota, Probiotics in Obesity: A Review.肠道微生物群与益生菌在肥胖中的相互作用:综述
Endocr Metab Immune Disord Drug Targets. 2018;18(3):212-220. doi: 10.2174/1871530318666180131092203.

引用本文的文献

1
New approaches to secondary metabolite discovery from anaerobic gut microbes.从厌氧肠道微生物中发现次生代谢产物的新方法。
Appl Microbiol Biotechnol. 2025 Jan 20;109(1):12. doi: 10.1007/s00253-024-13393-y.
2
Effects of Bifidobacterium and rosuvastatin on metabolic-associated fatty liver disease via the gut-liver axis.双歧杆菌和瑞舒伐他汀通过肠-肝轴对代谢相关脂肪性肝病的影响。
Lipids Health Dis. 2024 Dec 18;23(1):401. doi: 10.1186/s12944-024-02391-8.
3
Probiotic potential of Streptomyces levis strain HFM-2 isolated from human gut and its antibiofilm properties against pathogenic bacteria.
从人肠道中分离得到的链霉菌 HFM-2 的益生菌潜力及其对病原菌的抗生物膜特性。
BMC Microbiol. 2024 Jun 11;24(1):208. doi: 10.1186/s12866-024-03353-x.
4
Uncovering Microbial Composition of the Tissue Microenvironment in Bladder Cancer using RNA Sequencing Data.利用RNA测序数据揭示膀胱癌组织微环境中的微生物组成
J Cancer. 2024 Mar 4;15(8):2431-2441. doi: 10.7150/jca.93055. eCollection 2024.
5
Antioxidant and chemoprotective potential of Streptomyces levis strain isolated from human gut.从人体肠道分离出的链霉菌菌株的抗氧化和化学保护潜力
AMB Express. 2023 Jul 7;13(1):69. doi: 10.1186/s13568-023-01570-7.
6
A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.肠道微生物群衍生代谢物在肿瘤进展和癌症治疗中的研究进展
Adv Sci (Weinh). 2023 May;10(15):e2207366. doi: 10.1002/advs.202207366. Epub 2023 Mar 23.
7
Effect of a Fructose-Rich Diet on Gut Microbiota and Immunomodulation: Potential Factors for Multiple Sclerosis.富含果糖的饮食对肠道微生物群和免疫调节的影响:多发性硬化症的潜在因素。
Immunohorizons. 2023 Mar 1;7(3):213-227. doi: 10.4049/immunohorizons.2300008.
8
Explanatory integration and integrated explanations in Darwinian medicine and evolutionary medicine.达尔文医学和进化医学中的解释性综合与综合解释。
Theor Med Bioeth. 2023 Feb;44(1):1-20. doi: 10.1007/s11017-022-09594-z. Epub 2022 Oct 29.
9
: The biofactory of secondary metabolites.次生代谢产物的生物工厂。
Front Microbiol. 2022 Sep 29;13:968053. doi: 10.3389/fmicb.2022.968053. eCollection 2022.
10
Awareness of Obesity-Related Cancers: A Complex Issue.肥胖相关癌症的认知:一个复杂的问题。
Int J Environ Res Public Health. 2022 May 29;19(11):6617. doi: 10.3390/ijerph19116617.